Dekel Gelbman

Biography

As the founding CEO of FDNA, Dekel Gelbman leads the corporate and business strategy of a digital health company that develops artificial intelligence technologies and SaaS platforms used by thousands of clinical, research, and lab sites globally in the clinical genomics space. Before joining FDNA, Mr. Gelbman was a practicing corporate and transactional attorney working for leading law firms, including among others, Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates.

AI & Data Sciences Showcase: FDNA
FDNA was incorporated with a mission to give hope to children with rare diseases, and their families. About 1 in 10 people, or 30 million total, are living with a rare disease in the United States.

Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.

View the top 3 talks from PMWC here (password: top-videos).

Once you sign up you will get access to the top 3 talks from January’s PMWC.
We hate spam too, unsubscribe at any time.

Do not alert me again.